CL2012001029A1 - Tetrapeptidos que promueven el aumento de hsp70, sus estereoisomeros, mezclas de los mismos y/o sus sales cosmetica o farmaceuticamente aceptables; composicion cosmetica o farmaceutica que comprende al menos uno de dichos peptidos; y usos de los mismos para el cuidado de la piel, mucosa y/o cabello. - Google Patents

Tetrapeptidos que promueven el aumento de hsp70, sus estereoisomeros, mezclas de los mismos y/o sus sales cosmetica o farmaceuticamente aceptables; composicion cosmetica o farmaceutica que comprende al menos uno de dichos peptidos; y usos de los mismos para el cuidado de la piel, mucosa y/o cabello.

Info

Publication number
CL2012001029A1
CL2012001029A1 CL2012001029A CL2012001029A CL2012001029A1 CL 2012001029 A1 CL2012001029 A1 CL 2012001029A1 CL 2012001029 A CL2012001029 A CL 2012001029A CL 2012001029 A CL2012001029 A CL 2012001029A CL 2012001029 A1 CL2012001029 A1 CL 2012001029A1
Authority
CL
Chile
Prior art keywords
tetrapeptides
hsp70
cosmetically
stereoisomers
mucosa
Prior art date
Application number
CL2012001029A
Other languages
English (en)
Inventor
Serraima Carreno
Van Den Nest Win Cristina
Boneteana Sempere
Montiel Antonio Ferrer
Domenech Nuria Alminana
Cebria
Original Assignee
Lipotec Sa
Bcn Peptides Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43332253&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2012001029(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lipotec Sa, Bcn Peptides Sa filed Critical Lipotec Sa
Publication of CL2012001029A1 publication Critical patent/CL2012001029A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07—Tetrapeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
CL2012001029A 2009-10-23 2012-04-23 Tetrapeptidos que promueven el aumento de hsp70, sus estereoisomeros, mezclas de los mismos y/o sus sales cosmetica o farmaceuticamente aceptables; composicion cosmetica o farmaceutica que comprende al menos uno de dichos peptidos; y usos de los mismos para el cuidado de la piel, mucosa y/o cabello. CL2012001029A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25434009P 2009-10-23 2009-10-23
ES200930896A ES2358829B1 (es) 2009-10-23 2009-10-23 Péptidos útiles en el tratamiento y/o cuidado de la piel, mucosas y/o cabello y su uso en composiciones cosméticas o farmacéuticas.

Publications (1)

Publication Number Publication Date
CL2012001029A1 true CL2012001029A1 (es) 2012-09-14

Family

ID=43332253

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012001029A CL2012001029A1 (es) 2009-10-23 2012-04-23 Tetrapeptidos que promueven el aumento de hsp70, sus estereoisomeros, mezclas de los mismos y/o sus sales cosmetica o farmaceuticamente aceptables; composicion cosmetica o farmaceutica que comprende al menos uno de dichos peptidos; y usos de los mismos para el cuidado de la piel, mucosa y/o cabello.

Country Status (16)

Country Link
US (1) US8993716B2 (es)
EP (1) EP2490706B1 (es)
JP (1) JP5864425B2 (es)
KR (1) KR101813294B1 (es)
CN (1) CN102711790B (es)
AU (1) AU2010310108B2 (es)
BR (1) BR112012009264A2 (es)
CA (1) CA2778390A1 (es)
CL (1) CL2012001029A1 (es)
ES (2) ES2358829B1 (es)
IL (1) IL219239A (es)
MX (1) MX2012004625A (es)
RU (1) RU2557401C2 (es)
TW (1) TWI499425B (es)
WO (1) WO2011047868A2 (es)
ZA (1) ZA201202705B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI655213B (zh) 2012-07-13 2019-04-01 目立康股份有限公司 自我組織化肽衍生物的製造方法
RU2514003C1 (ru) * 2012-11-14 2014-04-27 Ольга Ивановна Бурлуцкая Комплексное косметическое средство
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US20140142522A1 (en) * 2012-11-16 2014-05-22 NU Technology, LLC Moist dressing with honeycomb pattern and drain channels
EP2740484A1 (en) * 2012-12-05 2014-06-11 Lipotec, S.A. Compounds useful in the treatment and/or care of the skin, hair and/or muccous membranes and their cosmetic or pharmaceutical compositions
KR102041803B1 (ko) * 2013-01-10 2019-11-07 (주) 수파드엘릭사 염증 또는 피부노화의 예방 또는 치료용 약학 조성물 및 염증 또는 피부노화 개선용 화장료 조성물
DK2976325T3 (en) 2013-03-21 2017-06-06 Sanofi Aventis Deutschland SYNTHESIS OF PEPTIDE PRODUCTS CONTAINING CYCLIC IMID
CA2907454C (en) 2013-03-21 2021-05-04 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
TWI516272B (zh) 2013-06-05 2016-01-11 財團法人工業技術研究院 應用於生髮之方法及醫藥組成物
KR101511425B1 (ko) * 2013-07-10 2015-04-13 한솔바이오 주식회사 나노 구조체
US9402876B2 (en) 2013-11-27 2016-08-02 Industrial Technology Research Institute Method and pharmaceutical composition for hair growth
CN111671658A (zh) 2014-01-27 2020-09-18 考司美德制药株式会社 遮瑕贴及其制造方法、肌肤美白护肤方法和抗痘护肤方法
EP2990027A1 (en) * 2014-09-01 2016-03-02 Institut Curie Skin whitening peptide agents
JP2017527580A (ja) * 2014-09-12 2017-09-21 ザ プロクター アンド ギャンブル カンパニー 老化防止スキンケア組成物及びレジメン
US10905646B2 (en) 2014-10-31 2021-02-02 Lubrizol Advanced Materials, Inc. Thermoplastic polyurethane film for delivery of active agents to skin surfaces
US9814670B2 (en) 2014-12-04 2017-11-14 Mary Kay Inc. Cosmetic compositions
RU2608901C2 (ru) * 2015-02-10 2017-01-26 Рамиль Рафаилевич Рахматуллин Персонализированное косметическое средство
CN108473652A (zh) 2015-11-05 2018-08-31 路博润先进材料公司 可热成型的双网络水凝胶组合物
EP4282476A3 (en) * 2015-12-18 2024-07-24 Mary Kay Inc. Topical cosmetic compositions
KR20180114911A (ko) 2016-02-04 2018-10-19 앨러스틴 스킨케어, 인크. 침습 및 비침습 시술적 피부 관리를 위한 조성물 및 방법
US10449349B2 (en) * 2016-12-14 2019-10-22 L'oreal Systems, devices, and methods including encapsulated cosmetics
KR102093209B1 (ko) 2017-05-11 2020-03-25 (주)케어젠 이소트레티노인과 펩타이드의 결합체
JP7201660B2 (ja) 2017-08-03 2023-01-10 アラスティン スキンケア，インク． 皮膚の弛緩と身体の輪郭を改善するための組成物および方法
US12097279B2 (en) 2017-09-18 2024-09-24 Mary Kay Inc. Cosmetic compositions and methods
US11147749B2 (en) 2017-10-04 2021-10-19 Mana Products, Inc. Dry composition for removing oils from hair and methods for fabrication of dry compositions
WO2020092851A1 (en) * 2018-10-31 2020-05-07 George Lambridis Dry composition for removing oils from hair and methods for fabrication of dry compositions
KR101898441B1 (ko) 2018-03-28 2018-09-13 (주)셀트리온 에피제네틱 조절 기능을 갖는 펩타이드를 포함하는 화장료 조성물 및 약학적 조성물
TWI795561B (zh) * 2018-05-02 2023-03-11 大江生醫股份有限公司 芒果果實萃取物及由其所得生物活性物質用於護膚及保健的用途
KR102282558B1 (ko) * 2018-07-06 2021-07-28 애니젠 주식회사 펩타이드 복합체를 유효성분으로 함유하는 미세먼지 제거 또는 흡착용 화장료 조성물
US11103455B2 (en) 2018-08-02 2021-08-31 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
EP3906013A1 (en) 2019-01-02 2021-11-10 The Procter & Gamble Company Skin care compositions containing peptide compound and aphanothece sacrum exopolysaccharide extract
KR102065171B1 (ko) 2019-02-20 2020-01-13 (주)케어젠 대기오염물질에 의한 피부 손상 방지 및 항노화용 펩타이드와 이의 용도
KR102203424B1 (ko) * 2019-03-15 2021-01-15 (주)진셀팜 Zdhhc13 유래 생리활성 펩타이드, 및 이의 용도
JP2022531076A (ja) * 2019-03-28 2022-07-06 リポトゥルー，エセ．エレ． 化粧品における使用のためのペプチドおよび組成物
IT201900008364A1 (it) * 2019-06-07 2020-12-07 Espikem S R L Peptidi bioattivi e composizioni che li comprendono
EP3831358A1 (en) * 2019-12-04 2021-06-09 Lipotrue, S.L. Peptides and compositions for use in cosmetics and medicine
CN111793116B (zh) * 2020-07-20 2022-03-04 广州和佳润颜医药有限公司 一种透皮七肽、含有该透皮七肽的美容组合物及制备方法
JPWO2022065415A1 (es) * 2020-09-24 2022-03-31
WO2022108439A1 (en) * 2020-11-18 2022-05-27 Wipro Manufacturing Services Sdn. Bhd. Method and compositions for skin microbiome normalization in sensitive skin
US11571378B2 (en) 2021-01-22 2023-02-07 The Procter & Gamble Company Skin care composition and method of using the same
US11771637B2 (en) 2021-01-22 2023-10-03 The Procter & Gamble Company Skin care composition and method of using the same
CN115340592B (zh) * 2021-09-09 2024-07-09 禾美生物科技(浙江)有限公司 一种活性肽及其相关用途
CN115990240A (zh) 2021-10-20 2023-04-21 富比积生物科技股份有限公司 寡肽在治疗牙龈发炎、牙龈萎缩及修复口腔黏膜中的用途
WO2023077339A1 (zh) * 2021-11-04 2023-05-11 深圳市维琪科技股份有限公司 一种四肽衍生物及其美容组合物或药用组合物和用途
KR20240086709A (ko) * 2022-11-18 2024-06-19 (주)케어젠 피부 상태 개선 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2504535B1 (fr) 1981-04-28 1987-08-14 Choay Sa Disaccharides derives d'un acide uronique et d'une glucosamine et compositions pharmaceutiques les contenant pour le controle de la coagulation sanguine
GB8519416D0 (en) 1985-08-01 1985-09-04 Unilever Plc Oligosaccharides
GB8630721D0 (en) 1986-12-23 1987-02-04 Unilever Plc Cosmetic compositions
GB8806892D0 (en) 1988-03-23 1988-04-27 Unilever Plc Lactams their synthesis & use in cosmetic compositions
GB8830019D0 (en) 1988-12-22 1989-02-15 Unilever Plc Cosmetic composition
GB8913708D0 (en) 1989-06-14 1989-08-02 Unilever Plc Cosmetic composition
US5348945A (en) 1990-04-06 1994-09-20 Wake Forest University Method of treatment with hsp70
US5942494A (en) 1995-10-06 1999-08-24 The Trustees Of Columbia University In The City Of New York Stimulation of gene expression and synthesis of heat shock protein 72/73 (HSP 70)
US20040228816A1 (en) 1998-12-30 2004-11-18 Carine Nizard Cosmetic or dermatological composition containing an active agent which stimulates synthesis of the protein HSP 32 in the skin
JP4873810B2 (ja) * 1999-10-05 2012-02-08 エピミューン インコーポレイテッド ペプチドおよび核酸組成物を使用する、ヒト免疫不全ウイルス−１に対する細胞性免疫応答の誘導
US20010034042A1 (en) * 2000-01-20 2001-10-25 Srivastava Pramod K. Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
US7405080B2 (en) 2000-03-23 2008-07-29 Voellmy Richard W Compositions and methods relating to prevention of chemotherapy-induced alopecia
US20040235813A1 (en) * 2001-05-03 2004-11-25 Erich Wanker Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
US7186693B2 (en) * 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
ES2321916T3 (es) 2001-11-14 2009-06-15 Larena Producto que contiene un extracto de alga roja del genero porphyra y sus utilizaciones para proteger las celulas.
FR2834887B1 (fr) 2002-01-24 2007-06-15 Vincience Utilisation d'un extrait d'artemia pour le traitement des peaux agees
GB0422525D0 (en) * 2004-10-11 2004-11-10 Luebcke Peter Dermatological compositions and methods
FR2876906B1 (fr) 2004-10-21 2007-04-13 Biolog Vegetale Yves Rocher Sa Utilisation cosmetique de mangiferine
MX2007007622A (es) 2004-12-22 2007-08-03 Gillette Co Reduccion del crecimiento del pelo.
EP2010565B1 (en) * 2006-04-21 2012-02-22 Agency for Science, Technology and Research Method for recombinant protein production in cho cells
MX2008013397A (es) * 2006-04-21 2009-03-27 Wyeth Corp Analisis de perfilamiento de expresion diferencial de fenotipos de cultivo celular y usos de los mismos.
WO2008109833A2 (en) * 2007-03-07 2008-09-12 University Of Florida Research Foundation, Inc. Polynucleotides and polypeptides identified by iviat screening and methods of use

Also Published As

Publication number Publication date
EP2490706A2 (en) 2012-08-29
US8993716B2 (en) 2015-03-31
RU2557401C2 (ru) 2015-07-20
CN102711790A (zh) 2012-10-03
JP5864425B2 (ja) 2016-02-17
KR20120105450A (ko) 2012-09-25
AU2010310108A1 (en) 2012-05-10
ES2358829B1 (es) 2012-06-25
WO2011047868A2 (en) 2011-04-28
ES2621542T3 (es) 2017-07-04
KR101813294B1 (ko) 2017-12-28
WO2011047868A3 (en) 2011-06-16
RU2012118581A (ru) 2013-11-27
ZA201202705B (en) 2013-06-26
TW201129368A (en) 2011-09-01
AU2010310108B2 (en) 2015-02-05
CN102711790B (zh) 2014-11-05
JP2013508322A (ja) 2013-03-07
MX2012004625A (es) 2012-08-23
ES2358829A1 (es) 2011-05-16
CA2778390A1 (en) 2011-04-28
US20130101662A1 (en) 2013-04-25
IL219239A0 (en) 2012-06-28
BR112012009264A2 (pt) 2021-09-08
IL219239A (en) 2017-06-29
EP2490706B1 (en) 2017-01-11
TWI499425B (zh) 2015-09-11

Similar Documents

Publication Publication Date Title
CL2012001029A1 (es) Tetrapeptidos que promueven el aumento de hsp70, sus estereoisomeros, mezclas de los mismos y/o sus sales cosmetica o farmaceuticamente aceptables; composicion cosmetica o farmaceutica que comprende al menos uno de dichos peptidos; y usos de los mismos para el cuidado de la piel, mucosa y/o cabello.
CO6430467A2 (es) Péptidos útiles en el tratamiento y/o cuidado de la piel y/o cabello y su uso en composiciones cosméticas o farmacéuticas
ES2330291B1 (es) Peptidos utiles en el tratamiento de la piel, mucosas y/o cuero cabelludo y su uso en composiciones cosmeticas o farmaceuticas.
IL214462A0 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
CO6791607A2 (es) Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
AR077764A1 (es) Polipeptidos selectivos para integrina alfavbeta 3 conjugados a una variante de seroalbumina humana (hsa) y usos farmaceuticos de los mismos
CO6640331A2 (es) Tratamiento anti-envejecimiento de la piel
BRPI0922686A2 (pt) associação de licopeno, polifenol e vitaminas para o cuidado das matérias queratínicas
PL2928484T3 (pl) Związki przydatne w leczeniu lub pielęgnacji skóry, włosów lub błon śluzowych oraz ich kompozycji kosmetycznych lub farmaceutycznych
CL2012001380A1 (es) Composición farmacéutica o cosmética que comprende el polipéptido coriolisina l, las proteínas muy ácidas vapi, vapii, vapiii, y una o más moléculas de ácido nucleico que codifican cualquiera de los polipéptidos recién mencionados; ácido nucleico; vector, célula hospedera; método de preparación de dichos polipéptidos; y método cosmético para exfoliar y/o humectar la piel de un animal.
BRPI0722043A2 (pt) composições de clareamento de pele cosmética tópicas e métodos de uso das mesmas.
BR112014013140A8 (pt) cosmética de prótese
AR072720A1 (es) Metodo para reducir la transpiracion y composicion desodorante antitranspirante
EP2724711A3 (de) Haarpflegemittel mit ausgewählten Aminosäuren und/oder ausgewählten Oligopeptiden und einem ausgewählten kationischen Keratinhydrolysat
DK1591105T3 (da) Anvendelse af antioxidanter til fremstilling af en farmaceutisk eller kosmetisk sammensætning for at beskytte huden mod skader som følge af infrarød stråling
IT1395122B1 (it) Composizione per uso farmaceutico o cosmetico o dietetico atta a svolgere un effetto di pigmentazione dei capelli
BR112012000115A2 (pt) composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, e o uso da dita composição como uma composição funcional ou terapêutica
BR112015029815A2 (pt) composição cosmética para clarear uma pele e/ou cabelo de um indivíduo, conjunto para clarear uma pele e/ou um cabelo de um individuo, método cosmético para clarear uma pele e/ou um cabelo de um individuo, composição cosmética ou farmacêutica para aplicação na pele, cabelo e/ou unha de um indivíduo, conjunto para aplicar uma composição cosmética ou farmacêutica na pele cabelo e/ou unha de um individuo e método de administração de peróxido de hidrogênio na pele, cabelo e/ou unha de indivíduo.
FR2998793B1 (fr) Composition cosmetique sous forme d'emulsion huile-dans-eau
BR112013029771A2 (pt) composição de proteção uv para aplicação tópica sobre a pele ou os cabelos, uso de uma composição de proteção uv, formulação cosmética e/ou farmacêutica, e uso
IT1393841B1 (it) Composizione farmaceutica o dermatologica o nutrizionale o cosmetica per combattere l'azione di immunosoppressione provocata sulla pelle da agenti aggressivi
CL2012003006A1 (es) Compuestos derivados de lactonas esteroideas insaturadas en la posicion 7(8) y sus sales y estereoisomeros farmaceuticamente aceptables; composicion farmaceutica que las comprende; y su uso para el tratamiento del cancer.
BR112015013125A2 (pt) tratamento de lesões orais usando composições de matrix placentário extracelular
WO2010117709A3 (en) Peptide-based systems for delivery of costmetic agents
UY31790A (es) Utilización de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administración de dronedarona